Ampio Pharmaceuticals, Inc. (AMPE) said its Board has approved a 20-to-1 reverse stock split of the company's common stock. The reverse stock split will become effective on September 11, 2023. The company's common stock is expected to begin trading on a split-adjusted basis on the NYSE American under the same symbol AMPE when the market opens on September 12, 2023.
The company said, as a result of the reverse stock split, every 20 shares of common stock issued and outstanding will be automatically reclassified into one share of common stock, with no change in the $0.0001 par value per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.